A Phase Ib/2 Clinical Study to Evaluate the Safety, Pharmacokinetic Characteristics and Preliminary Efficacy of Fruquintinib Combined With Paclitaxel in Patients With Advanced Gastric Cancer

Trial Profile

A Phase Ib/2 Clinical Study to Evaluate the Safety, Pharmacokinetic Characteristics and Preliminary Efficacy of Fruquintinib Combined With Paclitaxel in Patients With Advanced Gastric Cancer

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 02 Mar 2017

At a glance

  • Drugs Fruquintinib (Primary) ; Paclitaxel
  • Indications Gastric cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Hutchison MediPharma
  • Most Recent Events

    • 23 Feb 2017 Planned End Date changed from 1 Feb 2017 to 31 Mar 2017.
    • 23 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 31 Mar 2017.
    • 23 Feb 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top